Hotpennystocknews.com is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks. We propel those victors directly to your email inbox first ahead of the rest of the marketplace gets a prospect.
Los Angeles, CA -- (SBWIRE) -- 02/07/2014 -- Hotpennystocknews.com issues special report on - Creative Edge Nutrition Inc (FITX)
Creative Edge Nutrition, Inc. (OTC Pink :FITX) was created and committed to building a customer brand loyalty by developing a diverse portfolio of health – oriented nutrition products. Scientifically designed and formulated to enhance athletic performance and well being, manufactured in the United States. Many of their product formulations have been in existence for years; however, they continually review, update and improve their product formulas based upon new developments in nutritional science. Cenergy is poised to set the standard and is committed to excellence, creating a lifestyle easier than ever dreamed possible.
Creative Edge Nutrition has developed five product categories to enhance performance, according to your lifestyle.
Cenergy products have been formulated with absolute precision to maximize the human body’s potential and enable its users to train longer, recover faster, grow stronger, and compete harder.
Each one of Cenergy Nutrition’s products focuses on giving the best results with each serving. As individual products, they are among the elite in each of the sports nutrition categories in which they compete; but when taken in CENERGY (all together) the results are unparalled to anything you thought possible from a sports nutrition supplement.
The Cenergy Nutrition Team has over 35 years of combined experience in the sports nutrition industry. The Research and Development team spends countless hours analyzing and evaluating each ingredient to be used in a product concept; then beta tests these products in the gym at different usage levels to validate the effectiveness of the product.
FITX’s shares gained 11.43% to $0.0585. The company, on Feb. 3 said that in a previous press release it announced a collaborative deal in the operation of its future medical marijuana facility in Lakeshore, Ontario Canada. 8k filings with the SEC through our collaborative partner have led to confusion in the ownership held by Creative Edge Nutrition Inc. This is to clear up any confusion. Creative Edge Nutrition Inc. owns 75% of Cen Biotech, Inc.
Additionally, the company on Jan. 31 announce that it has entered into a licensing and operating agreement with RXNB Inc. RXNB Inc. has a portfolio valuation of $110 million dollars and approximately $27.5 million dollars in annual revenue. It represents a recent merger of a multitude of independent companies in the pharmaceutical and nutraceutical space.
Is Investor Showing Any Interest On FITX? Find Out Here.
Neither Hotpennystocknews.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by Hotpennystocknews.com, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation.Hotpennystocknews.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through Hotpennystocknews.com. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned here in.
Read Full disclaimer at:http://www.hotpennystocknews.com/disclaimer.php
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)